Literature DB >> 27083455

Factors associated with the incidence of serious adverse events in patients admitted with COPD acute exacerbation.

M-T García-Sanz1, J-C Cánive-Gómez2, N García-Couceiro3, L Senín-Rial3, S Alonso-Acuña3, A Barreiro-García3, E López-Val3, L Valdés4, F-J González-Barcala4.   

Abstract

BACKGROUND: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common cause of hospitalization. Patient outcome and prognosis following AECOPD are variable. The aim of this study is to identify the factors associated with the incidence of serious adverse events (SAE), defined as need for ICU admission, noninvasive ventilation, death during hospitalization or early readmission, in those patients admitted with AECOPD.
METHODS: We conducted a retrospective study by reviewing the medical records of all patients admitted with AECOPD in the University Hospital Complex of Santiago de Compostela in 2007 and 2008. To identify variables independently associated with SAE incidence, we conducted a logistic regression including those variables which proved to be significant in the univariate analysis.
RESULTS: 757 patients were assessed (mean age 74.8 years, SD 11.26), 77.2 % male, and 186 (24.6 %) of the patients assessed experienced an SAE. Factors associated with SAE in multivariate analysis were anticholinergic therapy (OR 3.19; CI 95 %: 1.16; 8.82), oxygen therapy at home (OR 3.72; CI 95 %: 1.62; 8.57), oxygen saturation at admission (OR 0.93; CI 95 %: 0.88; 0.99) and serum albumin (OR 0.26; CI 95 %: 0.1; 0.66).
CONCLUSION: Oxygen therapy at home, anticholinergic therapy as baseline treatment, lower oxygen saturation at admission and lower serum albumin level seem to be associated with higher incidence of SAE in patients with AECOPD.

Entities:  

Keywords:  COPD; Exacerbation; Serious adverse event

Mesh:

Year:  2016        PMID: 27083455     DOI: 10.1007/s11845-016-1431-9

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  39 in total

1.  Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.

Authors:  B R Celli; W MacNee
Journal:  Eur Respir J       Date:  2004-06       Impact factor: 16.671

2.  In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study.

Authors:  Chua Ai-Ping; Kang-Hoe Lee; Tow-Keang Lim
Journal:  Chest       Date:  2005-08       Impact factor: 9.410

3.  The effects of reversal of neuromuscular blockade on autonomic control in the perioperative period.

Authors:  J M van Vlymen; J L Parlow
Journal:  Anesth Analg       Date:  1997-01       Impact factor: 5.108

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 5.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

6.  Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease.

Authors:  Zinka Matkovic; Arturo Huerta; Nestor Soler; Rebeca Domingo; Albert Gabarrús; Antoni Torres; Marc Miravitlles
Journal:  Respiration       Date:  2012-02-11       Impact factor: 3.580

7.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

8.  Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.

Authors:  Andrea Gershon; Ruth Croxford; Andrew Calzavara; Teresa To; Matthew B Stanbrook; Ross Upshur; Thérèse A Stukel
Journal:  JAMA Intern Med       Date:  2013-07-08       Impact factor: 21.873

9.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

Authors:  J Garcia-Aymerich; E Farrero; M A Félez; J Izquierdo; R M Marrades; J M Antó
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

10.  Nutritional state during COPD exacerbation: clinical and prognostic implications.

Authors:  R Girón; C Matesanz; F García-Río; E de Santiago; A Mancha; F Rodríguez-Salvanés; J Ancochea
Journal:  Ann Nutr Metab       Date:  2009-03-02       Impact factor: 3.374

View more
  4 in total

1.  Factors Associated with Treatment Failure in Patients with Acute Exacerbation of COPD Admitted to the Emergency Department Observation Unit.

Authors:  Wasuntaraporn Pethyabarn; Sareeman Chewae; Ar-Aishah Dadeh
Journal:  Emerg Med Int       Date:  2020-06-29       Impact factor: 1.112

Review 2.  Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A meta-analysis.

Authors:  Hong-Lei Yin; Shi-Qi Yin; Qing-Yan Lin; Ying Xu; Hong-Wei Xu; Tao Liu
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

3.  Utility of Computed Tomography in a Differential Diagnosis for the Patients with an Initial Diagnosis of Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Hyung Jun Park; Soo Han Kim; Ho Cheol Kim; Bo Young Lee; Sei Won Lee; Jae Seung Lee; Sang Do Lee; Joon Beom Seo; Yeon Mok Oh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31

4.  Impact of anxiety and depression on the prognosis of copd exacerbations.

Authors:  Sandra Martínez-Gestoso; María-Teresa García-Sanz; José-Martín Carreira; Francisco-Javier Salgado; Uxío Calvo-Álvarez; Liliana Doval-Oubiña; Sandra Camba-Matos; Lorena Peleteiro-Pedraza; Miguel-Angel González-Pérez; Pedro Penela-Penela; Andrés Vilas-Iglesias; Francisco-Javier González-Barcala
Journal:  BMC Pulm Med       Date:  2022-04-29       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.